Again, talking about a newbie looking at RDGL right now as an FDA play. RDGL doesn't have visible catalysts yet to attract an FDA play buyer. Only thing that can turn page here is IDE submission/approval, and that's a few steps and months away at best. It is what it is. Just saying think MK is smart not to do a PR until at least animal test results submitted to FDA and meeting requested.